Powder: -20°C for 3 years
In solvent: -80°C for 2 years
AER-271 is an inhibitor of aquaporin-4.
Description | AER-271 is an inhibitor of aquaporin-4. |
In vivo | Treatment with AER-271 ameliorated early cerebral edema measured at 3 h after CA vs vehicle treated rats. This treatment also attenuated early NDS. In contrast to rats treated with vehicle after CA, rats treated with AER-271 did not develop significant neuronal death or neuroinflammation as compared to sham. |
Molecular Weight | 463.65 |
Formula | C15H9ClF6NO5P |
CAS No. | 634913-39-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 27.5 mg/mL (59.31 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AER-271 634913-39-6 Membrane transporter/Ion channel Aquaporin Inhibitor AQP4 AER-270 stroke inhibit aquaporin-4 injury AER 271 acute AER271 CNS ischemic inhibitor